Literature DB >> 2722101

[Pattern electroretinography and pattern visual evoked potentials in maculopathy: a comparison with sensory tests].

F Niermann, R Lorenz, W Heider.   

Abstract

The retinal and cortical potentials for pattern reversal were recorded in 58 eyes of 30 patients afflicted with macular disease. The highest incidence of abnormality (79%) was found for the amplitudes P-ERG and P-VECP. Total field EOG and L-ERG were affected less frequently (41% and 25%). The P-ERG amplitude correlated significantly with the sensitivity of the central 10 degrees visual field (static perimetry). The P-VECP threshold check size showed a close correlation with visual acuity. Thus, the recording of pattern-evoked retinal and cortical potentials serves as a supplementary means of assessing types of maculopathy.

Entities:  

Mesh:

Year:  1989        PMID: 2722101

Source DB:  PubMed          Journal:  Fortschr Ophthalmol        ISSN: 0723-8045


  4 in total

1.  Retinal origin of VECP delays as revealed by simultaneously recorded ERG to patterned stimuli.

Authors:  R Lorenz; W Heider
Journal:  Doc Ophthalmol       Date:  1990-08       Impact factor: 2.379

2.  Pattern electroretinogram, visual evoked potential and psychophysical functions in maculopathy.

Authors:  A Junghardt; H Wildberger; B Török
Journal:  Doc Ophthalmol       Date:  1995       Impact factor: 2.379

Review 3.  VEP estimation of visual acuity: a systematic review.

Authors:  Ruth Hamilton; Michael Bach; Sven P Heinrich; Michael B Hoffmann; J Vernon Odom; Daphne L McCulloch; Dorothy A Thompson
Journal:  Doc Ophthalmol       Date:  2020-06-02       Impact factor: 2.379

4.  Vision before and after scharioth macular lens implantation in patients with AMD: an electrophysiological study.

Authors:  Jan Kremláček; Jana Nekolová; Markéta Středová; Jana Langrová; Jana Szanyi; Miroslav Kuba; Zuzana Kubová; František Vít; Petr Voda; Martina Veselá; Naďa Jirásková
Journal:  Doc Ophthalmol       Date:  2021-01-03       Impact factor: 2.379

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.